Researchers have designed and constructed artificial circRNAs using enzymatic ligation in vitro, and these synthetic circRNAs can be stably expressed in cancer cells and efficiently function as miRNA sponges (e.g., miR-21 and miR-93) or protein sponges (e.g., hnRNP L) 9-11. Here, HNRNPL is linked to cancer.